Kowa Research Institute, Inc.
Clinical trials sponsored by Kowa Research Institute, Inc., explained in plain language.
-
New combo pill aims to halt liver scarring in NASH patients
Disease control CompletedThis completed Phase 2 study tested whether a combination of two experimental drugs, K-877-ER and CSG452, can improve liver health in adults with nonalcoholic steatohepatitis (NASH) and liver fibrosis. The 228 participants received either the combination or a placebo. The main go…
Phase: PHASE2 • Sponsor: Kowa Research Institute, Inc. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New eye drops aim to speed vision recovery after cornea surgery
Disease control CompletedThis study tested whether ripasudil eye drops can help people with Fuchs endothelial corneal dystrophy recover vision faster after a specific cornea procedure called descemetorhexis. The trial involved 107 adults and compared the drops to a placebo over 12 weeks of treatment, fol…
Phase: PHASE3 • Sponsor: Kowa Research Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New eye drops aim to speed vision recovery after cornea surgery
Disease control CompletedThis study tested whether ripasudil eye drops can help people with Fuchs endothelial corneal dystrophy recover vision faster after combined cataract and cornea surgery. 110 adults received either the eye drops or a placebo for 12 weeks, followed by a taper and 38-week follow-up. …
Phase: PHASE3 • Sponsor: Kowa Research Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC